Table 1.
Drug | Product Name | Development Status | Formulation |
---|---|---|---|
Tobramycin | Tobi®, Bramitob® | Marketed | LF, DP |
Levofloxacin | Aeroquin® | Phase III (NCT01270347, NCT01180634) * | LF |
Aztreonam lysine | Cayston® | Marketed | LF |
Colistimethate sodium | Promixin®, Colobreathe® | Marketed | LF, DP |
Azithromycin | Zithromax® | Marketed | |
Amikacin | Arikayce™ | Phase III (NCT01315678) * | LF |
Ciprofloxacin | Cipro Inhale® | Phase II (NCT00645788) * | DP |
LF: Liquid formulation, DP: Dry powder. * More information on clinicaltrials.gov.